In vivo pharmacokinetics and pharmacodynamics of ceftibuten/ledaborbactam, a novel oral β-lactam/β-lactamase inhibitor combination is a research paper published in Journal of Antimicrobial Chemotherapy (2022). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Department of Health and Human Services
Grant: HHSN272201600029C
National Institute of Allergy and Infectious Diseases
National Institutes of Health
Venatorx Pharmaceuticals, Inc.
MeSH Terms